RPG.F REGENT PACIFIC GRP

Healthcare Capital Markets Frankfurt Exchange
0.0920 EUR
Close of Nov 12, 2026
0.0590 0.1210
Market cap
EUR 26.8M
P/E
-
P/B
2.06x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is RPG.F undervalued?

Graham number

The Graham number of REGENT PACIFIC GRP cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

REGENT PACIFIC GRP fundamental analysis

No fundamental analysis for REGENT PACIFIC GRP yet.

REGENT PACIFIC GRP stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About REGENT PACIFIC GRP

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the …

Full company profile